Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis
Cancer cells are known to undergo metabolic adaptation to cater to their enhanced energy demand. Nicotinamide adenine dinucleotide (NAD) is an essential metabolite regulating many cellular processes within the cell. The enzymes required for NAD synthesis, starting from the base precursor - tryptopha...
Main Authors: | Adithya Chedere, Madhulika Mishra, Omkar Kulkarni, Shrisruti Sriraman, Nagasuma Chandra |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.954512/full |
Similar Items
-
Advances in NAD-Lowering Agents for Cancer Treatment
by: Moustafa S. Ghanem, et al.
Published: (2021-05-01) -
NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions
by: Niannian Wang, et al.
Published: (2022-11-01) -
Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression
by: Natasja Franceschini, et al.
Published: (2021-06-01) -
Identification of NAPRT Inhibitors with Anti-Cancer Properties by In Silico Drug Discovery
by: Moustafa S. Ghanem, et al.
Published: (2022-07-01) -
Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors
by: Jorge Franco, et al.
Published: (2022-07-01)